4-Level Pulmonary Embolism Clinical Probability Score (4PEPS)
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Very Low-5–-1
- Low0–5
- Moderate6–12
- High13–20
The 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) calculates stratifying pneumonia severity, respiratory failure progression, and inpatient admission requirements. Key inputs include age category. Scores guide determining appropriate admission level (floor versus ICU), tailoring antimicrobial therapy, and ventilatory support. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Clinical probability score for suspected pulmonary embolism using 13 clinical variables to safely decrease imaging testing needs
Clinical Indication
The 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) is indicated for bedside clinical practice to support Clinical probability score for suspected pulmonary embolism using 13 clinical variables to safely decrease imaging testing needs. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with community-acquired pneumonia, COPD exacerbations, acute asthma, pulmonary embolism, or acute respiratory distress. Clinical application is indicated across Respiratory care units, emergency pulmonary triage, sleep clinics, and medical floors.
Limitations & Contraindications
Peripheral pulse oximetry loses reliability in hypoperfusion, severe vasoconstriction, methemoglobinemia, or carboxyhemoglobinemia.
Clinical Pearls & Action Plan
Synchronous evaluation of arterial blood gas (PaO2/FiO2), mechanics of breathing, and clinical trajectory guides respiratory failure management. Guideline pearl: Score comprises 13 criteria that may be difficult to memorize - recommend using electronic calculator.
Sum of weighted clinical variables: Age <50 (-2), Age 50-64 (-1), Chronic respiratory disease (-1), Heart rate <80 (-1), Chest pain + dyspnea (+1), Male (+2), Hormonal treatment (+2), Personal history VTE (+2), Syncope (+2), Immobility 4 weeks (+2), O2 sat <95% (+3), Calf pain/edema (+3), PE most likely (+5)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age_category | string | Yes | Patient age category |
| chronic_respiratory_disease | string | Yes | Presence of chronic respiratory disease (COPD, asthma, pulmonary fibrosis, etc.) |
| heart_rate_under_80 | string | Yes | Heart rate less than 80 beats per minute |
| chest_pain_dyspnea | string | Yes | Presence of both chest pain and acute dyspnea |
| male_gender | string | Yes | Patient is male |
| hormonal_treatment | string | Yes | Hormonal estrogenic treatment (oral contraceptives, hormone replacement therapy) |
| personal_history_vte | string | Yes | Personal history of venous thromboembolism (DVT or PE) |
| syncope | string | Yes | Syncope (fainting episode) |
| immobility_4_weeks | string | Yes | Immobility within the last 4 weeks (bed rest, wheelchair, cast, etc.) |
| oxygen_saturation_under_95 | string | Yes | Pulse oxygen saturation less than 95% |
| calf_pain_edema | string | Yes | Calf pain and/or unilateral lower limb edema |
| pe_most_likely | string | Yes | PE is the most likely diagnosis (clinician's judgment) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| -5–-1 | Very Low | Very low clinical probability |
| 0–5 | Low | Low clinical probability |
| 6–12 | Moderate | Moderate clinical probability |
| 13–20 | High | High clinical probability |
Evidence-Based References (EBM)
- Roy PM, Friou E, Germeau B, Douillet D, Kline JA, Righini M, et al. Derivation and Validation of a 4-Level Clinical Pretest Probability Score for Suspected Pulmonary Embolism to Safely Decrease Imaging Testing. JAMA Cardiol. 2021 Jun 1;6(6):669-677. doi: 10.1001/jamacardio.2021.0064.DOI: 10.1001/jamacardio.2021.0064
- Stals MAM, Beenen LFM, Coppens M, Faber LM, Hofstee HMA, Hovens MMC, et al. Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism: An external validation study. Thromb Res. 2023 Nov;231:65-75. doi: 10.1016/j.thromres.2023.09.010.DOI: 10.1016/j.thromres.2023.09.010
- Chiang P, Robert-Ebadi H, Perrier A, Roy PM, Sanchez O, Righini M, et al. Pulmonary embolism risk stratification: external validation of the 4-level Clinical Pretest Probability Score (4PEPS). Res Pract Thromb Haemost. 2024 Feb 15;8(1):102348. doi: 10.1016/j.rpth.2024.102348.DOI: 10.1016/j.rpth.2024.102348